| Stage | TTMI | % of rev | CRS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.2B | 100.00% | $798M | 100.00% | TTMI ×1.51 |
| Gross profit | $292M | 24.24% | $256M | 32.11% | CRS +7.9pp |
| Operating income | $162M | 13.48% | $196M | 24.61% | CRS +11.1pp |
| Pre-tax income | $142M | 11.77% | $192M | 24.10% | CRS +12.3pp |
| Net income | $85M | 7.04% | $163M | 20.36% | CRS +13.3pp |
| Stage | TTMI | CRS | Gap · A − B |
|---|---|---|---|
| Revenue | $1.2B100.00% | $798M100.00% | TTMI ×1.51 |
| Gross profit | 24.24%$292M | 32.11%$256M | CRS +7.9pp |
| Operating income | 13.48%$162M | 24.61%$196M | CRS +11.1pp |
| Pre-tax income | 11.77%$142M | 24.10%$192M | CRS +12.3pp |
| Net income |
| 7.04%$85M |
| 20.36%$163M |
| CRS +13.3pp |
No disclosed counterparties: TTMI, CRS.